Literature DB >> 10072112

Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma.

J Huh1, K Cho, D S Heo, J E Kim, C W Kim.   

Abstract

One hundred thirty-seven patients with peripheral T-cell lymphomas (PTL) were examined for the presence of Epstein-Barr virus (EBV) using in situ hybridization for EBV-encoded RNA (EBER) and Bam H-fragment, lower strand frame (BHLF) and immunohistochemical stain for latent membrane protein (LMP). EBER was detected in tumor cells in 79 cases (58%); 26/66 PTL, unspecified (39%), 3/4 AILD (75%), 47/51 angiocentric lymphomas (AL) (92%), and 3/13 anaplastic large cell lymphoma (ALCL) (23%) by Revised European-American Lymphoma (REAL) classification. EBER was detected in 17/36 nodal (47%) vs. 62/101 extranodal PTLs (61%); 21/24 nasal, 12/32 Waldeyer's ring, 9/13 gastrointestinal, and 20/32 skin and soft tissue PTL. AL was consistently associated with the highest frequency of EBER among the extranodal PTL: nose (19/20), GI tracts (3/3), skin (14/15), and Waldeyer's ring (11/14). In extranodal lymphomas, coagulative-type zonal necrosis was seen almost exclusively in AL and showed correlation with EBER-positivity (P < 0.01). LMP was detected in 24 among 107 cases tested (22%). No signal for BHLF was detected in 76 cases tested, implying absent or negligible incidence of lytic infection. In conclusion, high incidence of EBV was observed in PTL among Koreans, with predilection for angiocentric lymphomas and extranodal presentation, especially involving nose, skin, and gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10072112     DOI: 10.1002/(sici)1096-8652(199903)60:3<205::aid-ajh7>3.0.co;2-j

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

1.  Epstein-Barr virus positive anaplastic large cell lymphoma: myth or reality?

Authors:  Ly Ma; Youval Katz; Kanu P Sharan; Roland Schwarting; Annette S Kim
Journal:  Int J Clin Exp Pathol       Date:  2010-11-20

2.  Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.

Authors:  Young Wha Koh; Dok Hyun Yoon; Cheolwon Suh; Hee Jeong Cha; Jooryung Huh
Journal:  Int J Exp Pathol       Date:  2015-04-27       Impact factor: 1.925

3.  Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.

Authors:  Bradley M Haverkos; Ying Huang; Alejandro Gru; Preeti Pancholi; Aharon G Freud; Anjali Mishra; Amy S Ruppert; Robert A Baiocchi; Pierluigi Porcu
Journal:  Int J Cancer       Date:  2017-04-15       Impact factor: 7.396

Review 4.  The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.

Authors:  A A Gru; B H Haverkos; A G Freud; J Hastings; N B Nowacki; C Barrionuevo; C E Vigil; R Rochford; Y Natkunam; R A Baiocchi; P Porcu
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

5.  Programmed death 1 expression in the peritumoral microenvironment is associated with a poorer prognosis in classical Hodgkin lymphoma.

Authors:  Young Wha Koh; Yoon Kyung Jeon; Dok Hyun Yoon; Cheolwon Suh; Jooryung Huh
Journal:  Tumour Biol       Date:  2015-12-17

6.  The ratio of the absolute lymphocyte count to the absolute monocyte count is associated with prognosis in Hodgkin's lymphoma: correlation with tumor-associated macrophages.

Authors:  Young Wha Koh; Hyo Jeong Kang; Chansik Park; Dok Hyun Yoon; Shin Kim; Cheolwon Suh; Heounjeong Go; Ji Eun Kim; Chul-Woo Kim; Jooryung Huh
Journal:  Oncologist       Date:  2012-05-15

7.  CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.

Authors:  Young Wha Koh; Chan-Sik Park; Dok Hyun Yoon; Cheolwon Suh; Jooryung Huh
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

8.  GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.

Authors:  Young Wha Koh; Jae-Ho Han; Seong Yong Park; Dok Hyun Yoon; Cheolwon Suh; Jooryung Huh
Journal:  J Pathol Transl Med       Date:  2017-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.